Fig. 6From: Lipo-MGN nanoparticle hypoxia attenuation-mediated single-dose radiotherapy- and pH/ROS-responsive T1 contrast magnetic resonance imaging in hepatocellular carcinomaEx vivo biodistribution of Lipo-MGNs by ICP-MS analysis in A HepG2 tumors at different time points and B organs at 8- and 24-h time points. The data are presented as the mean ± standard deviation with number of samples (n) = 5Back to article page